XML 69 R51.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Earnings (loss) per share (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2024
Schedule of Earnings per Share | The net income (loss) attributable to Teva and the weighted average number of ordinary shares used in the computation of basic and diluted earnings (loss) per share for the years ended December 31, 2024, 2023 and 2022 are as follows:
|  | Year ended December, 31 |
|  | 2024 |  |  | 2023 |  |  | 2022 |
|  | (U.S. $ in millions, except share data) |
Net income (loss) used for the computation of basic and diluted earnings (loss) per share |  | $ | (1,639 | ) |  | $ | (559 | ) |  | $ | (2,446 | )
Weighted average number of shares used in the computation of basic earnings (loss) per share |  |  | 1,131 |  |  |  | 1,119 |  |  |  | 1,110 |
Weighted average number of shares used in the computation of diluted earnings (loss) per share |  |  | 1,131 |  |  |  | 1,119 |  |  |  | 1,110 |

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration